Celldex Therapeutics CLDX
NASDAQ CLDX
$31.65 +0.16 (+0.51%)
As of: Sep 29, 2026 · 3:59 PM EDT

Celldex Therapeutics (CLDX) Total Current Liabilities (2010 - 2026)

Updated

Celldex Therapeutics (CLDX) posted Total Current Liabilities of $61.33 million for Q2 2026, up 86.0% from $32.96 million a year earlier and up 19.1% from the prior quarter.

Analysis

Celldex Therapeutics (CLDX) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Celldex Therapeutics' Total Current Liabilities came in at $50.99 million, up 29.1% from FY2024.

  • Annual Total Current Liabilities has increased for six consecutive years, with a five-year compound annual growth rate of 29.1% (FY2020 to FY2025).
  • In prior years, Celldex Therapeutics' Total Current Liabilities was $39.5 million in FY2024 (+26.9%), $31.13 million in FY2023 (+67.2%), $18.61 million in FY2022 (+12.6%) and $16.53 million in FY2021 (+16.3%).
  • The Q2 2026 figure stands as the highest quarterly Total Current Liabilities in data going back to Q4 2010.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last 12 quarters, with growth averaging 38.0% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q2 2022, with growth of 106.7%; the weakest was Q2 2023, with a decline of 47.8%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $51.47 million (Q1 2026), $50.99 million (Q4 2025) and $46.47 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Celldex Therapeutics 2.47 Bn 2.47 Bn - 61.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61.33 Mn
Mar 31, 2026 51.47 Mn
Dec 31, 2025 50.99 Mn
Sep 30, 2025 46.47 Mn
Jun 30, 2025 32.96 Mn
Mar 31, 2025 32.02 Mn
Dec 31, 2024 39.50 Mn
Sep 30, 2024 32.09 Mn
Jun 30, 2024 27.66 Mn
Mar 31, 2024 26.29 Mn
Dec 31, 2023 31.13 Mn
Sep 30, 2023 27.84 Mn
Jun 30, 2023 15.65 Mn
Mar 31, 2023 15.22 Mn
Dec 31, 2022 18.61 Mn
Sep 30, 2022 16.29 Mn
Jun 30, 2022 29.95 Mn
Mar 31, 2022 14.56 Mn
Dec 31, 2021 16.53 Mn
Sep 30, 2021 14.18 Mn
API Access

Celldex Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=CLDX&period=max&api_key=YOUR_API_KEY